JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB32124

Anti-Bcl-2 antibody [E17]

  • BOND RX™ Validated
  • RabMAb
  • Recombinant
  • KO Validated
  • 20ul selling size
  • What is this?

3

(14 Reviews)

|

(1706 Publications)

Anti-Bcl-2 antibody [E17] (ab32124) is a rabbit monoclonal antibody detecting Bcl-2 in Western Blot, IP, IHC-P. Suitable for Human.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 1300 publications
- Trusted since 2006

View Alternative Names

Apoptosis regulator Bcl-2, BCL2

16 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [E17] (AB32124)
  • IHC-P

PubMed

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [E17] (AB32124)

Immunohistochemical analysis of Human salivary glands taken from patients with primary Sjögren's syndrome, staining Bcl-2 with unpurified ab32124.
Antigen retrieval was performed via heat mediation in a citrate buffer (pH 6). Sections were blocked using 2% BSA, 10% normal serum and permeabilized with 0.5% Triton X-100. Samples were incubated with primary antibody (1/100) for one hour at room temperature. An Alexa Fluor® 594-conjugated anti-rabbit IgG was used as the secondary antibody.
N.B. Panels B and D are higher magnifications of panels A and C, respectively.

Image from Szyszko EA et al. Arthritis Res Ther. 2011 Jan 7;13(1):R2. Fig 5.; doi:10.1186/ar3220; 7 January 2011 Arthritis Research & Therapy 2011 13:R2.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [E17] (AB32124)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [E17] (AB32124)

Immunohistochemical analysis of formalin fixed paraffin embedded human lymphoma labelling Bcl-2 with ab32124 at a concentration of 1µg/ml.

The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins.

ab32124 anti- Bcl-2 antibody [E17] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.

Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [E17] (AB32124)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [E17] (AB32124)

Tissue Microarrays for Anti-Bcl2 antibody [E17] using ab32124 in immunohistochemical analysis. This table provides a detailed overview of positive (tick mark) and negative (cross mark) staining per sample type tested. The sections were pretreated with heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins. The section was incubated with ab32124 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [E17] (AB32124)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [E17] (AB32124)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human B-cell lymphoma tissue labelling Bcl-2 with purified ab32124 at 1/250. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. ab97051, a HRP-conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody (1/500). Negative control using PBS instead of primary antibody. Counterstained with hematoxylin.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [E17] (AB32124)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [E17] (AB32124)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human breast carcinoma tissue labelling Bcl-2 with unpurified ab32124 at 1/200 dilution. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [E17] (AB32124)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [E17] (AB32124)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human B cell lymphoma tissue labelling Bcl-2 with unpurified ab32124. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [E17] (AB32124)
  • IHC-P

AbReview52227****

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [E17] (AB32124)

Formaldehyde-fixed, paraffin-embedded human DLBCL U2932 cell line xenograft tissue stained for Bcl-2 using ab32124 at 1/200 dilution in immunohistochemical analysis, followed by Goat anti-Rabbit IgG Alexa Fluor® 555.

This image is courtesy of an anonymous Abreview.

Immunoprecipitation - Anti-Bcl-2 antibody [E17] (AB32124)
  • IP

Unknown

Immunoprecipitation - Anti-Bcl-2 antibody [E17] (AB32124)

ab32124 (purified) at 1/30 immunoprecipitating Bcl-2 in Jurkat (human T cell leukemia cell line from peripheral blood) cell lysate (Lane 1). Lane 2 - PBS. For western blotting, a HRP-conjugated anti-rabbit IgG, specific to the non-reduced form of IgG was used as the secondary antibody (1/1500).

Blocking buffer and concentration : 5% NFDM/TBST.

Diluting buffer and concentration : 5% NFDM /TBST.

All lanes:

Immunoprecipitation - Anti-Bcl-2 antibody [E17] (ab32124)

Predicted band size: 26 kDa

Observed band size: 26 kDa

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [E17] (AB32124)
  • IHC-P

PubMed

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [E17] (AB32124)

Bcl-2 expression determined by immunohistochemical analyses of the 4 human UM xenografts (between 3 to 5 tumors have been studied per condition).

Image from Némati F et al. PLoS One. 2014;9(1):e80836. Fig 2.; doi: 10.1371/journal.pone.0080836.

Western blot - Anti-Bcl-2 antibody [E17] (AB32124)
  • WB

Lab

Western blot - Anti-Bcl-2 antibody [E17] (AB32124)

Blocking buffer and concentration : 5% NFDM/TBST.

Diluting buffer and concentration : 5% NFDM /TBST.

MCF-7 cells express Bcl-2, while SK-BR-3 cells do not express Bcl-2 (PMID : 18430249)

All lanes:

Western blot - Anti-Bcl-2 antibody [E17] (ab32124) at 1/200 dilution

Lane 1:

MCF7 (human breast adenocarcinoma cell line) cell lysate at 10 µg

Lane 2:

SK-BR-3 (human mammary gland adenocarcinoma cell line) cell lysate at 10 µg

Secondary

All lanes:

Peroxidase-conjugated goat anti-rabbit IgG (H+L) at 1/50000 dilution

Predicted band size: 26 kDa

Observed band size: 26 kDa

false

Western blot - Anti-Bcl-2 antibody [E17] (AB32124)
  • WB

Lab

Western blot - Anti-Bcl-2 antibody [E17] (AB32124)

Lanes 1- 2 : Merged signal (red and green). Green - ab32124 observed at 26 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.

ab32124 was shown to react with BCL2 in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab255364 (knockout cell lysate ab263752) was used. Wild-type HeLa and BCL2 knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab32124 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Bcl-2 antibody [E17] (ab32124) at 1/1000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

BCL2 knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human BCL2 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-bcl2-knockout-hela-cell-line-ab255364'>ab255364</a>)

Predicted band size: 26 kDa

Observed band size: 26 kDa

false

Western blot - Anti-Bcl-2 antibody [E17] (AB32124)
  • WB

Lab

Western blot - Anti-Bcl-2 antibody [E17] (AB32124)

Blocking buffer and concentration : 5% NFDM/TBST.

Diluting buffer and concentration : 5% NFDM /TBST.

All lanes:

Western blot - Anti-Bcl-2 antibody [E17] (ab32124) at 1/1000 dilution

Lane 1:

MCF7 (human breast adenocarcinoma cell line) cell lysate at 20 µg

Lane 2:

A431 (human epidermoid carcinoma cell line) cell lysate at 20 µg

Secondary

All lanes:

Peroxidase-conjugated goat anti-rabbit IgG (H+L) at 1/1000 dilution

Predicted band size: 26 kDa

Observed band size: 26 kDa

false

Western blot - Anti-Bcl-2 antibody [E17] (AB32124)
  • WB

Lab

Western blot - Anti-Bcl-2 antibody [E17] (AB32124)

Lanes 1 - 4 : Merged signal (red and green). Green - ab32124 observed at 26 kDa. Red - loading control, ab8245, observed at 37 kDa.

ab32124 was shown to specifically react with BCL2 when BCL2 knockout samples were used. Wild-type and BCL2 knockout samples were subjected to SDS-PAGE. ab32124 and ab8245 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at 1000 dilution and 1/10000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging. 3% milk used as blocking agent.

All lanes:

Western blot - Anti-Bcl-2 antibody [E17] (ab32124)

Lane 1:

Wild-type HAP1 whole cell lysate at 20 µg

Lane 2:

BCL2 knockout HAP1 whole cell lysate at 20 µg

Lane 3:

HeLa whole cell lysate at 20 µg

Lane 4:

THP-1 whole cell lysate at 20 µg

Predicted band size: 26 kDa

false

Western blot - Anti-Bcl-2 antibody [E17] (AB32124)
  • WB

Unknown

Western blot - Anti-Bcl-2 antibody [E17] (AB32124)

All lanes:

Western blot - Anti-Bcl-2 antibody [E17] (ab32124) at 1/1000 dilution

All lanes:

Jurkat (human T cell leukemia cell line from peripheral blood) cell lysate

Predicted band size: 26 kDa

Observed band size: 26 kDa

false

Western blot - Anti-Bcl-2 antibody [E17] (AB32124)
  • WB

Lab

Western blot - Anti-Bcl-2 antibody [E17] (AB32124)

Blocking buffer and concentration : 5% NFDM/TBST.

Diluting buffer and concentration : 5% NFDM /TBST.

All lanes:

Western blot - Anti-Bcl-2 antibody [E17] (ab32124) at 1/10000 dilution

Lane 1:

Jurkat (human T cell leukemia cell line from peripheral blood) cell lysate at 20 µg

Lane 2:

HeLa (human epithelial cell line from cervix adenocarcinoma) cell lysate at 20 µg

Lane 3:

SH-SY5Y (human neuroblastoma cell line from bone marrow) cell lysate at 20 µg

Secondary

All lanes:

Peroxidase-conjugated goat anti-rabbit IgG (H+L) at 1/1000 dilution

Predicted band size: 26 kDa

Observed band size: 26 kDa

false

OI-RD Scanning - Anti-Bcl-2 antibody [E17] (AB32124)
  • OI-RD Scanning

Unknown

OI-RD Scanning - Anti-Bcl-2 antibody [E17] (AB32124)

We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

E17

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, IP, IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

This antibody recognises Bcl-2. It does not cross-react with other Bcl-2 family members.

Bcl-2 has two isoforms, one is around 26kDa and the other is around 20kDa (PMID: 26009263, PMID: 10400666, PMID: 32377726).

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/50", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p>We recommend using <a href='/en-us/products/primary-antibodies/bcl-2-antibody-epr17509-ab182858'>ab182858</a> for murine samples.</p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/250 - 1/500", "IHCP-species-notes": "<p>We do not recommend rat and mouse samples with IHC.</p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." } } }

Product details

What is this antibody validated in?
Anti-Bcl-2 antibody [E17] (ab32124) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC-P) in Human samples.

What is the molecular weight of Bcl-2?
Anti-Bcl-2 [E17] (ab32124) specifically detects a band for Bcl-2 (UniProt: P10415) at a molecular weight of 26kDa.

Trusted by the scientific community
Anti-Bcl-2 [E17] (ab32124) was first used in a scientific publication in 2006 and has been cited over 1300 times in peer-reviewed journals.

Reviewed by scientists
Anti-Bcl-2 [E17] (ab32124) has over 10 independent reviews from customers.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Specificity confirmed
The specificity of Anti-Bcl-2 antibody [E17] (ab32124) has been confirmed by Immunocytochemistry testing in BCL2 Knockout Hap1 cells.

Other related products
We have a range of other formats of antibody clone [E17] also available for your convenience: ab32124, Carrier free - ab185002, Carrier free - ab242335, Alexa Fluor® 488 - ab311028, Alexa Fluor® 647 - ab311154, Alexa Fluor® 594 - ab311800, Alexa Fluor® 568 - ab313083, Alexa Fluor® 555 - ab313277, Alexa Fluor® 750 - ab321578

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Species reactivity
Rat: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Bcl-2 also known as B-cell lymphoma 2 is an important protein involved in the regulation of apoptosis. It mechanically functions by inhibiting cell death and is a member of the Bcl-2 family of proteins. Bcl-2 has a molecular weight of approximately 26 kDa. It is expressed mainly in fetal and adult tissues including the immune system and is notably present in hematopoietic stem cells and various cell lines derived from lymphoid tissues. In laboratory practices scientists often assess Bcl-2 expression levels through techniques like western blotting using antibodies such as 10c4 for detection.
Biological function summary

The role of Bcl-2 extends to maintaining cell survival and balancing apoptotic signals. It functions as an anti-apoptotic molecule within the cell primarily involved in forming complexes with pro-apoptotic members of the Bcl-2 family like Bax and Bak. These interactions prevent mitochondrial membrane permeabilization which is an important step in apoptotic signal transduction. As an important regulator of apoptosis Bcl-2 helps in cellular homeostasis and appropriate immune responses under physiological conditions.

Pathways

Bcl-2 plays a critical role in the intrinsic or mitochondrial pathway of apoptosis. Within this pathway Bcl-2 interacts with other proteins such as cytochrome c and APAF-1 to inhibit apoptosis. This pathway involves a network of Bcl-2 family proteins where Bcl-2's anti-apoptotic role counteracts the pro-apoptotic activity of proteins like Bax. These interactions help fine-tune the apoptotic response to various internal stimuli maintaining cellular integrity and function.

The dysregulation of Bcl-2 expression has been implicated in cancer and autoimmune diseases. Overexpression of Bcl-2 is associated with several types of cancer including lymphomas and breast cancer where its anti-apoptotic property leads to tumor cell survival and resistance to chemotherapy. Bcl-2 also connects to disorders such as autoimmune diseases due to its regulation of cell survival with proteins like Bim playing an opposite role in promoting apoptosis. Understanding Bcl-2's functionality within these contexts is essential for developing targeted therapies.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells (PubMed : 1508712, PubMed : 8183370). Regulates cell death by controlling the mitochondrial membrane permeability (PubMed : 11368354). Appears to function in a feedback loop system with caspases (PubMed : 11368354). Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) (PubMed : 11368354). Also acts as an inhibitor of autophagy : interacts with BECN1 and AMBRA1 during non-starvation conditions and inhibits their autophagy function (PubMed : 18570871, PubMed : 20889974, PubMed : 21358617). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (PubMed : 17418785).
See full target information BCL2

Publications (1706)

Recent publications for all applications. Explore the full list and refine your search

Journal of biological methods 12:e99010066 PubMed40937375

2025

An experimental workflow for investigating anoikis resistance in cancer metastasis.

Applications

Unspecified application

Species

Unspecified reactive species

Xue Han,Yipan Zheng,Xiaohui Si,Zhe Liu

General physiology and biophysics 44:429-438 PubMed40923661

2025

Tripterygium glycosides alleviate CSE-induced lung injury by inhibiting IL-33 in bronchial epithelial cells.

Applications

Unspecified application

Species

Unspecified reactive species

Nan Zhang,Jian Fan,Zhiping Deng

Materials today. Bio 34:102234 PubMed40893347

2025

Cationic microbubble loading hSIRT3 and hTIMP3 optimize cardiac-targeted delivery and myocardial protection in the porcine MI/R model.

Applications

Unspecified application

Species

Unspecified reactive species

Peian Cai,Kegong Chen,Xionghai Qin,Xingpei Jiang,Xuan Jiao,Kexun Liu,Erliang Guo,Zipeng Li,Xianxin Qiu,Chang Liu,Lu Sun,Junbo Chuai,Jie Wu,Wei Chen,Hai Tian

Pharmaceuticals (Basel, Switzerland) 18: PubMed40872596

2025

Multiple Strategies Confirm the Anti Hepatocellular Carcinoma Effect of Cinnamic Acid Based on the PI3k-AKT Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Jiageng Guo,Lijiao Yan,Qi Yang,Huaying Li,Yu Tian,Jieyi Yang,Jinling Xie,Fan Zhang,Erwei Hao

Nature communications 16:7688 PubMed40841513

2025

Patient-derived tumoroids from CIC::DUX4 rearranged sarcoma identify MCL1 as a therapeutic target.

Applications

Unspecified application

Species

Unspecified reactive species

Willemijn Breunis,Eva Brack,Anna C Ehlers,Ingrid Bechtold,Samanta Kisele,Jakob Wurth,Lieke Mous,Dorita Zabele,Fabio Steffen,Felina Zahnow,Christian Britschgi,Lorenz Bankel,Christian Rothermundt,Cornelia Vetter,Daniel Müller,Sander Botter,Chantal Pauli,Peter Bode,Beate Rinner,Jean-Pierre Bourquin,Jochen Roessler,Thomas G P Grünewald,Beat W Schäfer,Didier Surdez,Marco Wachtel

Translational lung cancer research 14:2771-2787 PubMed40799432

2025

Overexpression of promotes cell metabolism and activates the NOTCH signaling pathway in lung adenocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Guangmin Xi,Caibo Zhang,Cong Yu,Yiya Wang,Jinfeng Fu,Haining Qi,Kenichi Suda,Guoying Wu

Scientific reports 15:29111 PubMed40781364

2025

Nanoparticle conjugation of ginsenoside Rh2 enhanced antitumor efficacy on hepatocellular carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Fengkai Sun,Jinkun Liu,Shuai Gao,Mingchen Zhang,Xiaoyan Sun,Yanan Tian,Shengchun Wang

BMC medicine 23:408 PubMed40624638

2025

Mitigation of chemotherapy-induced gut dysbiosis and diarrhea by supplementation with heat-killed Bacteroides fragilis.

Applications

Unspecified application

Species

Unspecified reactive species

Xinwen Yan,Xinlong Lin,Jianhua Wu,Lijun Zheng,Yangyang Liu,Fang Wu,Ying Lin,Yishi Lu,Chongyang Huang,Binhai Shen,Hongbin Liu,Ruo Huang,Fengyi Hou,Qian Zhou,Mengyao Song,Ke Liu,Fangqing Zhu,Sheng Li,Yuqing Lin,Wei Wang,Ping Li,Wangjun Liao,Fachao Zhi

European journal of medical research 30:582 PubMed40619436

2025

IFNα-IFITM1-ERK axis in corneal epithelial cell damage: implications for dry eye disease.

Applications

Unspecified application

Species

Unspecified reactive species

Hongjuan Peng,Siyi Li,Guiling Zhao,Suyin Peng,Yanhua Pang

Antioxidants (Basel, Switzerland) 14: PubMed40563254

2025

Ferulic Acid Combines with Ascorbic Acid to Target MMP9 to Attenuate Cisplatin-Induced Ototoxicity Through the p38MAPK Signaling Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Guojun Yang,Na Hu,Jie Gao,Xinzhi Li,Bin Zhang,Ketao Ma
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com